Illumina, Inc.
ILMNWhat is it worth to you? Move six assumptions and see what value per share you get, and where you stand against the price and other users.
Value Illumina, Inc. (ILMN) with your own assumptions and see where you stand against the price and other users.
Its accounts, year by year
| Year end | Sales | Growth | Margin |
|---|---|---|---|
| 01/2016 | 2,220 | — | 33.6% |
| 01/2017 | 2,398 | 8.0% | 29.9% |
| 12/2017 | 2,752 | 14.8% | 28.0% |
| 12/2018 | 3,333 | 21.1% | 32.3% |
| 12/2019 | 3,543 | 6.3% | 33.3% |
| 01/2021 | 3,239 | −8.6% | 23.9% |
| 01/2022 | 4,526 | 39.7% | 13.9% |
| 01/2023 | 4,584 | 1.3% | −83.2% |
| 12/2023 | 4,504 | −1.7% | −15.3% |
| 12/2024 | 4,372 | −2.9% | −10.6% |
| 12/2025 | 4,343 | −0.7% | 24.9% |
Sales in millions of dollars. The margin is the operating margin before stock pay, as a percentage of sales. Each row is a fiscal year, by the month it ends. Source: the reports Illumina, Inc. files with the SEC, the US securities regulator; the latest is for the fiscal year ended December 28, 2025. See the report.
The model's starting point
- Sales growth, years 1 to 10: −0.7% a year.
- Sales growth after year 10: 2.5% a year.
- Operating margin, before stock pay: −10.0% of sales.
- Working capital needed to grow: $5.7 per $100 of new sales.
- Capital spending: 4.3% of sales.
- Stock pay to employees: 5.8% of sales.
- Discount rate, the same for every company: 10%.
These are the six assumptions the page starts with; each user moves them as they see fit.
Reference points
They come from its accounts and its share price, compared with the median of the companies on grinboss. They are not a recommendation.
For
- Its sales grew 6.9% a year on average over 10 years, from $2.2 billion to $4.3 billion; the median of grinboss companies is 6.6%.
Against
- Its margin has fallen over these years, from 30% to −11%.
- It makes only −$11 of operating profit for every $100 it sells, before stock pay; the median is $18.
- It generated free cash flow in only 1 of the last 5 years.
- Its margin jumps from one year to the next: 23.6 points on average, and up to 97.1 in a single year; the median is 2.8 points.
Next results: January 12, 2027.
Other companies in its sector (Health Care)
Incyte (INCY) · IQVIA (IQV) · Intuitive Surgical (ISRG) · Johnson & Johnson (JNJ) · Labcorp (LH) · Lilly (Eli) (LLY) · McKesson (MCK) · Medtronic (MDT) · All companies
Loading the model…